Literature DB >> 12130443

Chronic hepatitis C activity: correlation with lymphadenopathy on MR imaging.

Xiao-Ming Zhang1, Donald G Mitchell, Hongyu Shi, George A Holland, Laurence Parker, Steven K Herrine, Denise Pasqualin, Raphael Rubin.   

Abstract

OBJECTIVE: To study the MR appearance of lymph nodes in relation to activity of chronic active hepatitis C, we correlated the findings on MR imaging with a histologic grading of the activity level.
MATERIALS AND METHODS: Fifty patients with chronic active hepatitis C, who had MR imaging examinations and a related histology report from a liver biopsy obtained within 1 month of the MR imaging were chosen from our radiology database and studied retrospectively. All patients were examined over a 4-year period at a single institution to detect cirrhosis or hepatocellular carcinoma. We divided the 50 patients into the mild, moderate, or severe activity groups, according to their histology reports. Two radiologists, unaware of the histologic classifications, individually reviewed the MR images to observe the perihepatic locations, number, size (defined as the sum of the length-by-width products of the largest three nodes), and intensity of the lymph nodes relative to the spleen. The clinical records of the patients were reviewed to check the results of their liver function tests. The lymph node findings on MR imaging were compared with the histologically confirmed activity level of chronic hepatitis C.
RESULTS: Forty-four (88.0%) of 50 patients had perihepatic lymph nodes larger than 5 mm on MR images, including 64.2% (9/14) of the patients with mild activity, 96.3% (26/27) of the patients with moderate activity, and 100% (9/9) of the patients with severe activity (p = 0.0034). The average number +/- the standard deviation (SD) of perihepatic lymph nodes was 2.5 +/- 1.8 in patients with mild activity, 5.6 +/- 2.2 in patients with moderate activity, and 8.3 +/- 3.5 in patients with severe activity (p = 0.0001). The average size (+/- SD) of the lymph nodes was 151.0 +/- 104.9 mm(2) in the mild activity group, 366.8 +/- 143.0 mm(2) in the moderate activity group, and 488.2 +/- 244.8 mm(2) in the severe activity group (p = 0.0001). On fat-saturated fast spin-echo T2-weighted MR images, the average number (+/- SD) of hyperintense nodes was 0.17 +/- 0.25 in the mild activity group, 1.7 +/- 0.80 in the moderate activity group, and 2.4 +/- 0.60 nodes in the severe activity group (p = 0.0001). No relationship between histologic activity and results from liver function tests was found.
CONCLUSION: MR imaging depicts perihepatic lymph nodes in most patients with chronic hepatitis C. Lymph node number, size, and hyperintensity were related to the activity of chronic hepatitis C, but the results of liver function tests were not.

Entities:  

Mesh:

Year:  2002        PMID: 12130443     DOI: 10.2214/ajr.179.2.1790417

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  4 in total

1.  Diagnosis of cirrhosis by spiral computed tomography: a case-control study with feature analysis and assessment of interobserver agreement.

Authors:  Alexander Keedy; Antonio C Westphalen; Aliya Qayyum; Rizwan Aslam; Alexander V Rybkin; Mei-Hsiu Chen; Fergus V Coakley
Journal:  J Comput Assist Tomogr       Date:  2008 Mar-Apr       Impact factor: 1.826

2.  Chronic hepatitis B: Enlarged perihepatic lymph nodes correlated with hepatic histopathology.

Authors:  Jian Shu; Jian-Nong Zhao; Fu-Gang Han; Guang-Cai Tang; Yin-Deng Luo; Li Luo; Xin Chen
Journal:  World J Radiol       Date:  2013-05-28

3.  Perihepatic nodes detected by point-of-care ultrasound in acute hepatitis and acute-on-chronic liver disease.

Authors:  I Che Feng; Szu Jen Wang; Ming Jen Sheu; Lok-Beng Koay; Ching Yih Lin; Chung Han Ho; Chi Shu Sun; Hsing Tao Kuo
Journal:  World J Gastroenterol       Date:  2015-11-28       Impact factor: 5.742

4.  Perihepatic lymphadenopathy in children with chronic viral hepatitis.

Authors:  Dagmar Schreiber-Dietrich; Margret Pohl; Xin-Wu Cui; Barbara Braden; Christoph F Dietrich; Liliana Chiorean
Journal:  J Ultrason       Date:  2015-06-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.